3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
16
Breast Neoplasms
13
Lung Neoplasms
9
Carcinoma, Renal Cell
7
Rectal Neoplasms
5
Pancreatic Neoplasms
5
Neoplasms
5
Lymphoma
5
Colorectal Neoplasms
5
Colonic Neoplasms
5
Uterine Cervical Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Glioblastoma
4
Esophageal Neoplasms
4
Breast Neoplasms, Male
4
Sarcoma
3
Melanoma
3
Lymphoma, Large B-Cell, Diffuse
3
Kidney Neoplasms
3
Hodgkin Disease
3
Head and Neck Neoplasms
3
Esophageal Squamous Cell Carcinoma
3
Brain Neoplasms
3
Adenocarcinoma Of Esophagus
3
Urinary Bladder Neoplasms
2
Unspecified Adult Solid Tumor, Protocol Specific
2
Thyroid Neoplasms
2
Thyroid Cancer, Papillary
2
Stomach Neoplasms
2
Spinal Cord Neoplasms
2
Interventions
Enoxaparin
4
Saline Solution
3
Warfarin
2
Tinzaparin
2
Dalteparin
2
Aspirin
2
enoxaparin sodium
1
edoxaban
1
alvocidib
1
Watchful Waiting
1
Tranexamic Acid
1
Sodium Chloride
1
Sodium Bicarbonate
1
Nadroparin
1
Lenalidomide
1
Ketoconazole
1
Immunoenzyme Techniques
1
High-Energy Shock Waves
1
Heparin, Low-Molecular-Weight
1
Heparin
1
Gemcitabine
1
Fondaparinux
1
Fluorodeoxyglucose F18
1
Fluoridation
1
Estramustine
1
Enzyme-Linked Immunosorbent Assay
1
Doxorubicin
1
Docetaxel
1
Clopidogrel
1
Bleeding Time
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Thromboembolism
×
Fluorodeoxyglucose F18
×
Clear all
NCT00964275
2014-12-08
MVTEP
University Hospital, Brest
Phase NA
Completed
400 enrolled